Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-021012
Filing Date
2021-08-23
Accepted
2021-08-23 16:31:12
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 926856
2 ex31-1.htm EX-31.1 9466
3 ex32-1.htm EX-32.1 4529
  Complete submission text file 0001493152-21-021012.txt   5313338

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE qnta-20210630.xsd EX-101.SCH 46352
5 XBRL CALCULATION FILE qnta-20210630_cal.xml EX-101.CAL 66136
6 XBRL DEFINITION FILE qnta-20210630_def.xml EX-101.DEF 223121
7 XBRL LABEL FILE qnta-20210630_lab.xml EX-101.LAB 392249
8 XBRL PRESENTATION FILE qnta-20210630_pre.xml EX-101.PRE 314773
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 695350
Mailing Address 632 S GLENWOOD PL BURBANK CA 91506
Business Address 632 S GLENWOOD PL BURBANK CA 91506 (818) 940-1617
QUANTA INC (Filer) CIK: 0001691430 (see all company filings)

EIN.: 812749032 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56025 | Film No.: 211197350
SIC: 2833 Medicinal Chemicals & Botanical Products